top of page

Artificial Intelligence in Drug Discovery:

Focus on Oncology Q3 2021

The main aim of this report is to profile the ecosystem of biotech companies and technology developers which apply advanced data analytics and knowledge extraction technologies, such as deep learning, for drug discovery in Oncology -- one of the most broad and crowded therapeutic areas of the pharmaceutical R&D and biotech investment.


This overview highlights leading AI-driven companies, their investors, selected collaborations with pharma corporations, relative expertise of such companies, level of their funding, examples of deals and collaborations, as well as examples of AI-applications by selected companies. This is an overview analysis to help the reader understand what is happening in the industry currently and possibly give an idea of what is coming next.

55 Pages
(Teaser)-AI-in-Drug-Discovery-Focus-on-Oncology-Q3-2021 (2).png
AI for Drug Discovery 
Focus on Oncology
One Pager
One_Pager_Artificial_Intelligence_in_Drug_Discovery_Focus_on_Oncology (3).png
bottom of page